MRNP41, an abbreviation for mRNA-binding protein 41, is a vital component of the mRNA ribonucleoprotein (mRNP) complex, crucial for the post-transcriptional regulation of gene expression. It plays a pivotal role in various mRNA processing events, including splicing, export, localization, translation, and decay. Functionally, MRNP41 exerts its influence through interactions with specific RNA sequences and motifs within mRNA molecules, facilitated by its multiple RNA-binding domains. Through these interactions, MRNP41 modulates mRNA stability and turnover, affecting their susceptibility to degradation by ribonucleases. Additionally, MRNP41 is involved in the spatial control of gene expression by participating in mRNA localization and transport within the cell, contributing to the precise subcellular localization of specific proteins.
The inhibition of MRNP41 presents a potential strategy for modulating gene expression and disrupting cellular processes dependent on mRNA metabolism. Various mechanisms can be employed to inhibit MRNP41 activity, including interference with its expression, post-translational modifications, or interactions with other cellular components. Inhibition of MRNP41 expression can be achieved through transcriptional silencing or degradation of its mRNA transcripts, effectively reducing the pool of active protein within the cell. Post-translational modifications such as phosphorylation, acetylation, or methylation can also be targeted to disrupt MRNP41 function, impairing its RNA-binding affinity and specificity. Furthermore, interference with the interactions between MRNP41 and other proteins or RNA molecules within the mRNP complex can hinder its ability to regulate mRNA metabolism effectively. Overall, inhibition of MRNP41 represents a potential avenue for perturbing gene expression programs and unraveling the intricate mechanisms governing mRNA dynamics in eukaryotic cells.
SEE ALSO...
Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
---|---|---|---|---|---|---|
Leptomycin B | 87081-35-4 | sc-358688 sc-358688A sc-358688B | 50 µg 500 µg 2.5 mg | $105.00 $408.00 $1224.00 | 35 | |
Binds specifically to exportin 1 (CRM1), a key nuclear export protein that might indirectly affect RAE1 function by altering nuclear-cytoplasmic transport dynamics. | ||||||
KPT 330 | 1393477-72-9 | sc-489062 | 5 mg | $170.00 | ||
A selective inhibitor of nuclear export proteins, including CRM1, which may alter the export of RNA molecules that RAE1 would typically handle. | ||||||
BMH-21 | 896705-16-1 | sc-507460 | 10 mg | $165.00 | ||
A small molecule that binds to RNA polymerase I, potentially altering RAE1-dependent mRNA export by affecting the synthesis of ribosomal RNA. | ||||||
CX-5461 | 1138549-36-6 | sc-507275 | 5 mg | $240.00 | ||
Inhibits RNA polymerase I, thus potentially affecting the levels of ribosomal RNA and indirectly the RAE1-mediated mRNA export. | ||||||
Pladienolide B | 445493-23-2 | sc-391691 sc-391691B sc-391691A sc-391691C sc-391691D sc-391691E | 0.5 mg 10 mg 20 mg 50 mg 100 mg 5 mg | $290.00 $5572.00 $10815.00 $25000.00 $65000.00 $2781.00 | 63 | |
Targets the spliceosome, thereby potentially affecting pre-mRNA splicing and indirectly the pool of mRNA RAE1 exports. | ||||||
Triptolide | 38748-32-2 | sc-200122 sc-200122A | 1 mg 5 mg | $88.00 $200.00 | 13 | |
Inhibits transcriptional activity, thereby potentially reducing the overall mRNA levels that RAE1 might export. | ||||||
Flavopiridol | 146426-40-6 | sc-202157 sc-202157A | 5 mg 25 mg | $78.00 $254.00 | 41 | |
Inhibits cyclin-dependent kinases, which could indirectly affect RAE1 function by altering cell cycle-dependent mRNA export processes. | ||||||
Ivermectin | 70288-86-7 | sc-203609 sc-203609A | 100 mg 1 g | $56.00 $75.00 | 2 | |
A broad-spectrum antiparasitic agent that can also modulate host nuclear transport proteins and may indirectly affect RAE1 activity. |